Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable

Blood

Volumn 100, Issue 2, 2002, Pages 560-568

  Levéen, Per ^a,b   Larsson, Jonas ^a,b   Ehinger, Mats ^a,b   Cilio, Corrado M ^a,b   Sundler, Martin ^a,b   Sjöstrand, Lottie Jansson ^a,b   Holmdahl, Rikard ^a,b   Karlsson, Stefan ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; GENE MUTATION; HEMATOPOIETIC CELL; INFLAMMATORY DISEASE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 0037100520     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.2.560     Document Type: Article

References (45)

1. Transforming growth factor-beta: A general review
2. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta)
3. Molecular and cell biology of TGF-beta
4. Localization of transforming growth factor-beta type I and type II receptors in mouse development
5. Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo
6. Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues
7. TGF-beta receptors and signalling mechanisms
8. Murine models define the role of TGF-beta as a master regulator of immune cell function
9. Inflammation and TGF beta 1: Lessons from the TGF beta 1 null mouse
10. Regulation of immune responses by TGF-beta
11. Transforming growth factor-betas are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation
12. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth
13. Early human thymocyte proliferation is regulated by an externally controlled autocrine transforming growth factor-beta 1 mechanism
14. Interleukin 7 (murine pre-B cell growth factor/lymphopoietin 1) stimulates thymocyte growth: Regulation by transforming growth factor beta
15. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4- dependent T cell-cycle progression
16. Effect of transforming growth factor-beta on early and late activation events in human T cells
17. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors: Autocrine inhibition of cellular proliferation and differentiation to immune killer cells
18. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms
19. TGF-beta 1 is a potent inducer of human effector T cells
20. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1
21. Control of CD4 effector fate: Transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion
22. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
23. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death
24. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated
25. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse
26. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression
27. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
28. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor beta II receptor
29. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting
30. Conditional gene targeting
31. Inducible gene targeting in mice using the Cre/lox system
32. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis
33. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
34. Positive and negative regulation of type II TGF-beta receptor signal transduction by autophosphorylation on multiple serine residues
35. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice
36. Inducible gene targeting in mice
37. Transforming growth factor-beta: Pleiotropic role in the regulation of hematopoiesis
38. Immune dysregulation in TGF-beta 1-deficient mice
39. Maternal rescue of transforming growth factor-beta 1 null mice
40. Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-beta 1
41. Transforming growth factor-beta 1 serves as an autocrine inhibitor of human endothelial cell/lymphocyte adhesion
42. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
43. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: Aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype
44. Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice